Heart failure clinic boosts use of Life-Saving drugs, study finds

NCT ID NCT07217106

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at whether a dedicated clinic focused on guideline-directed medical therapy (GDMT) helps heart failure patients get the right combination of medications. Researchers analyzed data from 342 patients at Massachusetts General Hospital who attended the GDMT clinic and compared them to similar patients receiving usual care. The goal was to see if more patients in the clinic received all four recommended drug classes and at higher doses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Guideline-Directed Medical Therapy (GDMT) clinic
What this could lead to: If successful, this approach could help more heart failure patients receive the full set of recommended medications, potentially improving their heart function and quality of life.
What could go wrong: This is a retrospective, observational study, not a randomized trial, so results may be influenced by patient selection. The findings may not apply to all heart failure patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Novartis

East Hanover, New Jersey, 07936, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.